Showing 211-220 of 2104 results for "".
Optimizing FcRn Therapy: Addressing and Reducing Adverse Reactions
https://practicalneurology.com/programs/cme/optimizing-fcrn-therapy-addressing-and-reducing-adverse-reactions/32243/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.The Science Behind FcRn Antagonists: A Deep Dive Into Their Mechanism of Action
https://practicalneurology.com/programs/cme/the-science-behind-fcrn-antagonists-a-deep-dive-into-their-mechanism-of-action/32241/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.Balancing Risk and Benefit: Traditional MG Treatments and Medications to Avoid
https://practicalneurology.com/programs/cme/balancing-risk-and-benefit-traditional-mg-treatments-and-medications-to-avoid/32240/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.Headache Horizons: The Study and Use of Psychedelics in Cluster Headache
https://practicalneurology.com/diseases-diagnoses/headache-pain/headache-horizons-the-study-and-use-of-psychedelics-in-cluster-headache/32032/Psychedelics have a history of use in headache disorders and evidence exists for their therapeutic benefit in cluster headache.Poststroke Cognitive Impairment and Dementia
https://practicalneurology.com/diseases-diagnoses/stroke/poststroke-cognitive-impairment-and-dementia/32189/A summary of the classification, epidemiology, evaluation, diagnosis, and management of poststroke cognitive impairment and dementia.Clinical Use of Dementia Biomarkers to Evaluate Cognitive Deficits in People With Primary Psychiatric Disorders
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/clinical-use-of-dementia-biomarkers-to-evaluate-cognitive-deficits-in-people-with-primary-psychiatric-disorders/32101/Biomarkers may assist in identifying whether symptoms are the result of the primary psychiatric process or a neurodegenerative process.Traumatic Brain Injury in Older Adults: Epidemiology, Management, Outcomes
https://practicalneurology.com/diseases-diagnoses/tbi/traumatic-brain-injury-in-older-adults-epidemiology-management-outcomes/31987/Unique features of traumatic brain injuries in older adults and the current landscape of treatment and management optionsPosttraumatic Headache Associated with Mild Traumatic Brain Injury
https://practicalneurology.com/diseases-diagnoses/tbi/posttraumatic-headache-associated-with-mild-traumatic-brain-injury/31993/Diagnosis and treatment of posttraumatic headache associated with mTBI, including onset, headache characteristics, and persistenceMedical Marijuana and Movement Disorders
https://practicalneurology.com/diseases-diagnoses/movement-disorders/medical-marijuana-and-movement-disorders/31951/Medical marijuana can be a useful tool for addressing nonmotor symptoms of movement disorders.The Central Vein Sign
https://practicalneurology.com/diseases-diagnoses/imaging-testing/the-central-vein-sign/31627/Is 1.5 T MRI still relevant for diagnosis of multiple sclerosis?